Temporary G codes are assigned to services and procedures that are under review before being included in the CPT coding system. Payment for these services is under the jurisdiction of the local carriers.


  • G2161

    Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period
  • G2162

    Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period
  • G2163

    Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
  • G2164

    Patient had a prior influenza virus vaccine adverse reaction any time before or during the measurement period
  • G2165

    Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period; or did not have a prior influenza virus vaccine adverse reaction any time before or during the measurement period
  • G2166

    Patient refused to participate at admission and/or discharge; patient unable to complete the neck fs prom at admission or discharge due to cognitive deficit, visual deficit, motor deficit, language barrier, or low reading level, and a suitable proxy/recorder is not available; patient self-discharged early; medical reason
  • G2167

    Residual score for the neck impairment successfully calculated and the score was less than zero (< 0)
  • G2168

    Services performed by a physical therapist assistant in the home health setting in the delivery of a safe and effective physical therapy maintenance program, each 15 minutes
  • G2169

    Services performed by an occupational therapist assistant in the home health setting in the delivery of a safe and effective occupational therapy maintenance program, each 15 minutes
  • G2170

    Percutaneous arteriovenous fistula creation (avf), direct, any site, by tissue approximation using thermal resistance energy, and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization) when performed, and includes all imaging and radiologic guidance, supervision and interpretation, when performed


  • Continued
  • G2171

    Percutaneous arteriovenous fistula creation (avf), direct, any site, using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, wen performed) and fistulogram(s), angiography, enography, and/or ultrasound, with radiologic supervision and interpretation, when performed
  • G2172

    All inclusive payment for services related to highly coordinated and integrated opioid use disorder (oud) treatment services furnished for the demonstration project
  • G2173

    Uri episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)
  • G2174

    Uri episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date
  • G2175

    Episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)
  • G2176

    Outpatient, ed, or observation visits that result in an inpatient admission
  • G2177

    Acute bronchitis/bronchiolitis episodes when the patient had a new or refill prescription of antibiotics (table 1) in the 30 days prior to the episode date
  • G2178

    Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure, for example patient bilateral amputee; patient has condition that would not allow them to accurately respond to a neurological exam (dementia, alzheimer's, etc.); patient has previously documented diabetic peripheral neuropathy with loss of protective sensation
  • G2179

    Clinician documented that patient had medical reason for not performing lower extremity neurological exam
  • G2180

    Clinician documented that patient was not an eligible candidate for evaluation of footwear as patient is bilateral lower extremity amputee
  • G2181

    Bmi not documented due to medical reason or patient refusal of height or weight measurement
  • G2182

    Patient receiving first-time biologic and/or immune response modifier therapy
  • G2183

    Documentation patient unable to communicate and informant not available
  • G2184

    Patient does not have a caregiver
  • G2185

    Documentation caregiver is trained and certified in dementia care
  • G2186

    Patient /caregiver dyad has been referred to appropriate resources and connection to those resources is confirmed
  • G2187

    Patients with clinical indications for imaging of the head: head trauma
  • G2188

    Patients with clinical indications for imaging of the head: new or change in headache above 50 years of age
  • G2189

    Patients with clinical indications for imaging of the head: abnormal neurologic exam
  • G2190

    Patients with clinical indications for imaging of the head: headache radiating to the neck


  • Continued
  • G2191

    Patients with clinical indications for imaging of the head: positional headaches
  • G2192

    Patients with clinical indications for imaging of the head: temporal headaches in patients over 55 years of age
  • G2193

    Patients with clinical indications for imaging of the head: new onset headache in pre-school children or younger (<6 years of age)
  • G2194

    Patients with clinical indications for imaging of the head: new onset headache in pediatric patients with disabilities for which headache is a concern as inferred from behavior
  • G2195

    Patients with clinical indications for imaging of the head: occipital headache in children
  • G2196

    Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method
  • G2197

    Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user
  • G2198

    Documentation of medical reason(s) for not screening for unhealthy alcohol use using a systematic screening method (e.g., limited life expectancy, other medical reasons)
  • G2199

    Patient not screened for unhealthy alcohol use using a systematic screening method
  • G2200

    Patient identified as an unhealthy alcohol user received brief counseling
  • G2201

    Documentation of medical reason(s) for not providing brief counseling (e.g., limited life expectancy, other medical reasons)
  • G2202

    Patient did not receive brief counseling if identified as an unhealthy alcohol user
  • G2203

    Documentation of medical reason(s) for not providing brief counseling if identified as an unhealthy alcohol user (e.g., limited life expectancy, other medical reasons)
  • G2204

    Patients between 45 and 85 years of age who received a screening colonoscopy during the performance period
  • G2205

    Patients with pregnancy during adjuvant treatment course
  • G2206

    Patient received adjuvant treatment course including both chemotherapy and her2-targeted therapy
  • G2207

    Reason for not administering adjuvant treatment course including both chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4; karnofsky <=50), cardiac contraindications, insufficient renal function, insufficient hepatic function, other active or secondary cancer diagnoses, other medical contraindications, patients who died during initial treatment course or transferred during or after initial treatment course)
  • G2208

    Patient did not receive adjuvant treatment course including both chemotherapy and her2-targeted therapy
  • G2209

    Patient refused to participate
  • G2210

    Residual score for the neck impairment not measured because the patient did not complete the neck fs prom at initial evaluation and/or near discharge, reason not given